These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2857469)

  • 1. Zetidoline, a novel neuroleptic, activates nigral dopaminergic neurons in rats.
    Mereu G; Fanni B; Collu M; Diena A; Glasser A
    Life Sci; 1985 Feb; 36(5):459-64. PubMed ID: 2857469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)-Sulpiride activates the firing rate and tyrosine hydroxylase activity of dopaminergic neurons in unanesthetized rats.
    Mereu G; Casu M; Gessa GL
    Brain Res; 1983 Mar; 264(1):105-10. PubMed ID: 6133578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment.
    Skarsfeldt T
    Synapse; 1992 Jan; 10(1):25-33. PubMed ID: 1346943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphine.
    Mereu G; Collu M; Ongini E; Biggio G; Gessa GL
    Eur J Pharmacol; 1985 May; 111(3):393-6. PubMed ID: 3894035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.
    Bowery B; Rothwell LA; Seabrook GR
    Br J Pharmacol; 1994 Jul; 112(3):873-80. PubMed ID: 7921615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin-releasing effect of zetidoline, a new neuroleptic agent, in the rat.
    Galliani G; Restelli A; Rosina R; Glässer A
    Pharmacol Res Commun; 1984 Feb; 16(2):117-27. PubMed ID: 6150500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine-stimulated adenylate cyclase in rat substantia nigra: localization and effects of neuroleptics.
    Spano PF; Di Chiara G; Loddo P; Tonon GC; Trabucchi M
    Adv Biochem Psychopharmacol; 1977; 16():613-6. PubMed ID: 18903
    [No Abstract]   [Full Text] [Related]  

  • 8. Responsiveness to 'autoreceptor' doses of apomorphine inversely correlated with the firing rate of dopaminergic A9 neurons: action of baclofen.
    Mereu G; Muntoni F; Calabresi P; Romani F; Boi V; Gessa GL
    Neurosci Lett; 1986 Apr; 65(2):161-6. PubMed ID: 3714103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depolarization inactivation of dopamine neurons: an artifact?
    Mereu G; Lilliu V; Vargiu P; Muntoni AL; Diana M; Gessa GL
    J Neurosci; 1995 Feb; 15(2):1144-9. PubMed ID: 7869090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of risperidone, clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons of the rat brain.
    Bruggeman R; Westerink BH; Timmerman W
    Eur J Pharmacol; 1997 Apr; 324(1):49-56. PubMed ID: 9137912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat.
    Fà M; Mereu G; Ghiglieri V; Meloni A; Salis P; Gessa GL
    Synapse; 2003 Apr; 48(1):1-9. PubMed ID: 12557266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal extracellular dopamine levels in rats with haloperidol-induced depolarization block of substantia nigra dopamine neurons.
    Moore H; Todd CL; Grace AA
    J Neurosci; 1998 Jul; 18(13):5068-77. PubMed ID: 9634572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of L-DOPA on nigral dopamine neurons and local field potential: comparison with apomorphine and muscimol.
    Xu D; Karain B; Brantley E; Shi WX
    J Pharmacol Exp Ther; 2011 May; 337(2):533-9. PubMed ID: 21330359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of nigral dopamine neurons by systemic and local apomorphine: possible contribution of dendritic autoreceptors.
    Akaoka H; Charléty P; Saunier CF; Buda M; Chouvet G
    Neuroscience; 1992 Aug; 49(4):879-91. PubMed ID: 1359456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro modulation of the firing rate of dopamine neurons in the rat substantia nigra pars compacta and the ventral tegmental area by antipsychotic drugs.
    Werkman TR; Kruse CG; Nievelstein H; Long SK; Wadman WJ
    Neuropharmacology; 2001 Jun; 40(7):927-36. PubMed ID: 11378163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Firing properties of substantia nigra dopaminergic neurons in freely moving rats.
    Freeman AS; Meltzer LT; Bunney BS
    Life Sci; 1985 May; 36(20):1983-94. PubMed ID: 3990520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.
    Chiodo LA; Bunney BS
    J Neurosci; 1983 Aug; 3(8):1607-19. PubMed ID: 6135762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zetidoline blocks dopamine autoreceptors in the rat substantia nigra.
    Harris NC; Pinnock RD; Woodruff GN
    Neuropharmacology; 1985 Jan; 24(1):33-6. PubMed ID: 2858831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects after repeated treatment with haloperidol, clozapine, thioridazine and tefludazine on SNC and VTA dopamine neurones in rats.
    Skarsfeldt T
    Life Sci; 1988; 42(10):1037-44. PubMed ID: 2894601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCH 23390, a selective D1 dopamine receptor blocker, enhances the firing rate of nigral dopaminergic neurons but fails to activate striatal tyrosine hydroxylase.
    Onali P; Mereu G; Olianas MC; Bunse B; Rossetti Z; Gessa GL
    Brain Res; 1985 Aug; 340(1):1-7. PubMed ID: 2862956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.